Healthy Inc > Blog > treatment of musculoskeletal pain
Posted on:

What is diclofenac sodium 50mg and Paracetamol used for?

In the pharmaceutical industry, the combination of Diclofenac Sodium (50 mg) and Paracetamol (325 mg or 500 mg) is one of the most widely prescribed Fixed-Dose Combinations (FDCs) for analgesia. As a pharmacist, I view this as a “dual-pathway” strategy: it combines the potent peripheral anti-inflammatory action of Diclofenac with the central analgesic and antipyretic effects of Paracetamol.

Primary Clinical Uses

  • Acute Musculoskeletal Pain: Highly effective for backaches, sprains, strains, and sports injuries where both pain and inflammation are present.

  • Post-Operative Recovery: Used to manage moderate-to-severe pain following surgical or dental procedures.

  • Arthritic Flare-ups: Provides symptomatic relief for acute episodes of Rheumatoid Arthritis, Osteoarthritis, and Ankylosing Spondylitis.

  • Gynaecological Pain: Frequently prescribed for severe primary dysmenorrhea (period pain).

  • Dental Pain: Effective for toothaches and post-extraction inflammation.

Mechanism of Action: The “Synergistic Punch”

This combination targets pain from two different angles:

Diclofenac Sodium (NSAID): It primarily inhibits the COX-2 enzyme, blocking the production of prostaglandins at the site of injury (periphery). This reduces the actual swelling and redness of the tissue.

Paracetamol (Analgesic/Antipyretic): While its exact mechanism is still debated, it is believed to act primarily on the Central Nervous System (CNS). It increases the overall pain threshold and reduces fever by acting on the heat-regulating center of the hypothalamus.

By combining them, you achieve a “sparing effect”—using a moderate dose of each to get a stronger result than a high dose of either alone, which often leads to a better safety profile for the patient.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, this FDC is a high-volume “bread and butter” product for export:

  • Bilayer vs. Monolithic Tablet: As a WHO-GMP manufacturer, we often look at the stability of the two APIs. While they are generally compatible, we ensure strict moisture control during granulation to prevent the degradation of Paracetamol.

  • Gastric Protection: Diclofenac is known for GI irritation. We often use enteric-coated Diclofenac pellets or specialized film-coating for the tablet to protect the stomach lining, enhancing patient compliance.

  • Global Demand & Tenders: This combination is a staple for B2B distributors and government health tenders in Africa, Southeast Asia, and the CIS. It is a highly competitive but high-turnover product.

  • Packaging for Stability: We prioritize Alu-Alu or high-grade PVC/PVDC blister packaging to ensure a stable 36-month shelf life in Zone IVb (hot and humid) climates.

  • Regulatory Compliance: Our Mumbai facility provides full CTD/eCTD Dossiers and comparative dissolution data to assist our international partners with registration.

Paracetamol Diclofenac sodium tablets

 

Posted on:

What is diclofenac potassium and Paracetamol tablets used for?

In the pharmaceutical industry, the combination of Diclofenac Potassium (50 mg) and Paracetamol (325 mg or 500 mg) is a powerhouse Fixed-Dose Combination (FDC). As a pharmacist, you recognize this as a “dual-pathway” analgesic strategy that provides superior relief compared to using either agent alone, making it a staple for acute and chronic pain management.

Primary Clinical Uses

  • Musculoskeletal Pain: Highly effective for backaches, sprains, strains, and sports-related injuries where both pain and localized swelling are present.

  • Arthritic Conditions: Used to manage acute flares of Rheumatoid Arthritis, Osteoarthritis, and Ankylosing Spondylitis by reducing joint stiffness and inflammation.

  • Post-Operative & Post-Traumatic Pain: Frequently prescribed after surgeries or dental procedures (like tooth extractions) to manage inflammation-driven pain.

  • Acute Dental & ENT Pain: Targeted relief for severe toothaches, earaches, and throat pain.

  • Gynae-related Pain: Effective for primary dysmenorrhea (painful menstrual cramps) due to its potent anti-prostaglandin activity.

Mechanism of Action: The Synergistic Advantage

This combination addresses pain from two different physiological directions:

Diclofenac Potassium (Peripheral Action): It is a potent NSAID that inhibits COX-1 and COX-2 enzymes. By blocking the synthesis of prostaglandins at the site of injury, it directly reduces inflammation, swelling, and localized pain. The “Potassium” salt is chosen for its rapid dissolution, ensuring a faster onset of action than the sodium version.

Paracetamol (Central Action): It primarily acts on the Central Nervous System (CNS) to increase the overall pain threshold. It also serves as an antipyretic (fever reducer). While it has minimal anti-inflammatory effect, it complements Diclofenac by providing a second layer of pain relief.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing standpoint, this FDC is a high-volume product requiring precise pharmaceutical engineering:

  • Bilayer Tablet Formulation: As a WHO-GMP manufacturer, we often utilize bilayer technology to separate the two active ingredients. This can be used to create a “Fast-Release” Paracetamol layer and a “Sustained-Release” Diclofenac layer, ensuring immediate relief with prolonged anti-inflammatory coverage.

  • Excipient Synergy: We focus on the selection of super-disintegrants to ensure that the Diclofenac Potassium reaches peak plasma concentration ($T_{max}$) as quickly as possible, justifying the “fast-acting” label.

  • Packaging for Stability: Due to the hygroscopic nature of Paracetamol and the light sensitivity of Diclofenac, we utilize Alu-Alu blister packaging or high-grade PVC/PVDC. This ensures a 36-month shelf life for export to hot and humid Zone IVb climates.

  • Dossier Support: Our Mumbai facility provides comprehensive CTD/eCTD Dossiers and comparative dissolution studies (IP/BP/USP) to help international B2B partners register the product in African, Southeast Asian, and Middle Eastern markets.

Paracetamol Diclofenac potassium caffeine tablet

 

Add to cart